NCT03211013View on ClinicalTrials.gov

Study of the Effects of Oxytocin on Attentional Bias and Startle in PTSD

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

June 9, 2021

Study Completion Date

June 9, 2021

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Oxytocin

single-dose administration of OT nasal spray, complete computer-based tasks post-dose for approximately 1 hour

DRUG

Placebos

single-dose administration of placebo nasal spray, complete computer-based tasks post-dose for approximately 1 hour

Trial Locations (1)

94025

VA Palo Alto Health Care System, Menlo Park

All Listed Sponsors
lead

Palo Alto Veterans Institute for Research

OTHER

NCT03211013 - Study of the Effects of Oxytocin on Attentional Bias and Startle in PTSD | Biotech Hunter | Biotech Hunter